FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

764283003: Semaglutide (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3647335010 Semaglutide (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3647336011 Semaglutide en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Semaglutide Is a Substance with glucagon-like peptide 1 receptor agonist mechanism of action (substance) true Inferred relationship Existential restriction modifier
Semaglutide Has disposition Hormone false Inferred relationship Existential restriction modifier
Semaglutide Is a Peptide true Inferred relationship Existential restriction modifier
Semaglutide Has disposition Glucagon-like peptide 1 receptor agonist true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing semaglutide Has active ingredient True Semaglutide Inferred relationship Existential restriction modifier 1
Product containing semaglutide in oral dose form (medicinal product form) Has active ingredient True Semaglutide Inferred relationship Existential restriction modifier 1
Product containing semaglutide in parenteral dose form (medicinal product form) Has active ingredient True Semaglutide Inferred relationship Existential restriction modifier 1
Semaglutide Has active ingredient True Semaglutide Inferred relationship Existential restriction modifier 1
Product containing only semaglutide in oral dose form (medicinal product form) Has active ingredient True Semaglutide Inferred relationship Existential restriction modifier 1
Product containing only semaglutide in parenteral dose form (medicinal product form) Has active ingredient True Semaglutide Inferred relationship Existential restriction modifier 1
Product containing precisely semaglutide 1.34 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Semaglutide Inferred relationship Existential restriction modifier 1
Product containing precisely semaglutide 1.34 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Semaglutide Inferred relationship Existential restriction modifier 1
Product containing precisely semaglutide 3 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Semaglutide Inferred relationship Existential restriction modifier 1
Product containing precisely semaglutide 3 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Semaglutide Inferred relationship Existential restriction modifier 1
Product containing precisely semaglutide 7 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Semaglutide Inferred relationship Existential restriction modifier 1
Product containing precisely semaglutide 7 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Semaglutide Inferred relationship Existential restriction modifier 1
Product containing precisely semaglutide 14 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Semaglutide Inferred relationship Existential restriction modifier 1
Product containing precisely semaglutide 14 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Semaglutide Inferred relationship Existential restriction modifier 1
Ozempic 0.25mg/0.19ml solution for injection 1.5ml pre-filled pens (Pharmaram Ltd) 1 pre-filled disposable injection Has specific active ingredient True Semaglutide Inferred relationship Existential restriction modifier
Ozempic 0.25mg/0.19ml solution for injection 1.5ml pre-filled pens (Pharmaram Ltd) Has specific active ingredient True Semaglutide Inferred relationship Existential restriction modifier
Ozempic 1mg/0.74ml solution for injection 3ml pre-filled pens (Pharmaram Ltd) 1 pre-filled disposable injection Has specific active ingredient True Semaglutide Inferred relationship Existential restriction modifier
Ozempic 0.5mg/0.37ml solution for injection 1.5ml pre-filled pens (Pharmaram Ltd) Has specific active ingredient True Semaglutide Inferred relationship Existential restriction modifier
Ozempic 1mg/0.74ml solution for injection 3ml pre-filled pens (Pharmaram Ltd) Has specific active ingredient True Semaglutide Inferred relationship Existential restriction modifier
Ozempic 0.5mg/0.37ml solution for injection 1.5ml pre-filled pens (Pharmaram Ltd) 1 pre-filled disposable injection Has specific active ingredient True Semaglutide Inferred relationship Existential restriction modifier
Semaglutide 7mg tablets Has specific active ingredient True Semaglutide Inferred relationship Existential restriction modifier
Semaglutide 14mg tablets Has specific active ingredient True Semaglutide Inferred relationship Existential restriction modifier
Semaglutide 3mg tablets Has specific active ingredient True Semaglutide Inferred relationship Existential restriction modifier
Semaglutide 7mg tablets Has active ingredient False Semaglutide Inferred relationship Existential restriction modifier
Semaglutide 14mg tablets 30 tablet Has specific active ingredient True Semaglutide Inferred relationship Existential restriction modifier
Rybelsus 14mg tablets (Novo Nordisk Ltd) Has specific active ingredient True Semaglutide Inferred relationship Existential restriction modifier
Semaglutide 3mg tablets Has active ingredient False Semaglutide Inferred relationship Existential restriction modifier
Semaglutide 3mg tablets 30 tablet Has specific active ingredient True Semaglutide Inferred relationship Existential restriction modifier
Semaglutide 14mg tablets Has active ingredient False Semaglutide Inferred relationship Existential restriction modifier
Rybelsus 14mg tablets (Novo Nordisk Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Semaglutide Inferred relationship Existential restriction modifier
Rybelsus 3mg tablets (Novo Nordisk Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Semaglutide Inferred relationship Existential restriction modifier
Rybelsus 3mg tablets (Novo Nordisk Ltd) Has specific active ingredient True Semaglutide Inferred relationship Existential restriction modifier
Rybelsus 7mg tablets (Novo Nordisk Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Semaglutide Inferred relationship Existential restriction modifier
Rybelsus 7mg tablets (Novo Nordisk Ltd) Has specific active ingredient True Semaglutide Inferred relationship Existential restriction modifier
Semaglutide 7mg tablets 30 tablet Has specific active ingredient True Semaglutide Inferred relationship Existential restriction modifier
Semaglutide 0.25mg/0.19ml solution for injection 1.5ml pre-filled disposable device Has specific active ingredient True Semaglutide Inferred relationship Existential restriction modifier
Semaglutide 0.5mg/0.37ml solution for injection 1.5ml pre-filled disposable device Has specific active ingredient True Semaglutide Inferred relationship Existential restriction modifier
Semaglutide 1mg/0.74ml solution for injection 3ml pre-filled disposable device Has specific active ingredient True Semaglutide Inferred relationship Existential restriction modifier
Ozempic 0.25mg/0.19ml solution for injection 1.5ml pre-filled pens (Novo Nordisk Ltd) Has specific active ingredient True Semaglutide Inferred relationship Existential restriction modifier
Ozempic 0.5mg/0.37ml solution for injection 1.5ml pre-filled pens (Novo Nordisk Ltd) Has specific active ingredient True Semaglutide Inferred relationship Existential restriction modifier
Ozempic 1mg/0.74ml solution for injection 3ml pre-filled pens (Novo Nordisk Ltd) Has specific active ingredient True Semaglutide Inferred relationship Existential restriction modifier
Semaglutide 1mg/0.74ml solution for injection 3ml pre-filled disposable device 1 pre-filled disposable injection Has specific active ingredient True Semaglutide Inferred relationship Existential restriction modifier
Semaglutide 0.5mg/0.37ml solution for injection 1.5ml pre-filled disposable device 1 pre-filled disposable injection Has specific active ingredient True Semaglutide Inferred relationship Existential restriction modifier
Semaglutide 0.25mg/0.19ml solution for injection 1.5ml pre-filled disposable device 1 pre-filled disposable injection Has specific active ingredient True Semaglutide Inferred relationship Existential restriction modifier
Ozempic 0.25mg/0.19ml solution for injection 1.5ml pre-filled pens (Novo Nordisk Ltd) 1 pre-filled disposable injection Has specific active ingredient True Semaglutide Inferred relationship Existential restriction modifier
Ozempic 0.5mg/0.37ml solution for injection 1.5ml pre-filled pens (Novo Nordisk Ltd) 1 pre-filled disposable injection Has specific active ingredient True Semaglutide Inferred relationship Existential restriction modifier
Ozempic 1mg/0.74ml solution for injection 3ml pre-filled pens (Novo Nordisk Ltd) 1 pre-filled disposable injection Has specific active ingredient True Semaglutide Inferred relationship Existential restriction modifier
Semaglutide Has active ingredient False Semaglutide Inferred relationship Existential restriction modifier
Semaglutide 0.25mg/0.19ml solution for injection 1.5ml pre-filled disposable device Has active ingredient False Semaglutide Inferred relationship Existential restriction modifier
Semaglutide 0.5mg/0.37ml solution for injection 1.5ml pre-filled disposable device Has active ingredient False Semaglutide Inferred relationship Existential restriction modifier
Semaglutide 1mg/0.74ml solution for injection 3ml pre-filled disposable device Has active ingredient False Semaglutide Inferred relationship Existential restriction modifier
Ozempic 0.25mg/0.19ml solution for injection 1.5ml pre-filled pens (Novo Nordisk Ltd) Has active ingredient True Semaglutide Inferred relationship Existential restriction modifier
Ozempic 0.5mg/0.37ml solution for injection 1.5ml pre-filled pens (Novo Nordisk Ltd) Has active ingredient True Semaglutide Inferred relationship Existential restriction modifier
Ozempic 1mg/0.74ml solution for injection 3ml pre-filled pens (Novo Nordisk Ltd) Has active ingredient True Semaglutide Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start